Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.2 to v3.4.3, with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-03-12T01:05:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous v3.4.1 funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:55:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A general government funding notice and a minor site revision (Revision: v3.4.1) were added; these changes do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:32:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor textual updates: glossary display control added, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new page revision tag 'v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:32:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added revision v3.3.4 and removed revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:00:47.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include a full list of study sites across the U.S. (Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Washington) and Canada (Alberta, Ontario, Quebec) with Revision: v3.3.3. The previous location blocks were removed and the HHS Vulnerability Disclosure section was deleted (transitioning from v3.3.2 to v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T09:10:28.000Z thumbnail image

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.